These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7655002)

  • 1. Human Rh D monoclonal antibodies (BRAD-3 and BRAD-5) cause accelerated clearance of Rh D+ red blood cells and suppression of Rh D immunization in Rh D- volunteers.
    Kumpel BM; Goodrick MJ; Pamphilon DH; Fraser ID; Poole GD; Morse C; Standen GR; Chapman GE; Thomas DP; Anstee DJ
    Blood; 1995 Sep; 86(5):1701-9. PubMed ID: 7655002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal anti-D development programme.
    Kumpel BM
    Transpl Immunol; 2002 Aug; 10(2-3):199-204. PubMed ID: 12216950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma half-lives and bioavailability of human monoclonal Rh D antibodies BRAD-3 and BRAD-5 following intramuscular injection into Rh D-negative volunteers.
    Goodrick J; Kumpel B; Pamphilon D; Fraser I; Chapman G; Dawes B; Anstee D
    Clin Exp Immunol; 1994 Oct; 98(1):17-20. PubMed ID: 7923878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo studies of monoclonal anti-D and the mechanism of immune suppression.
    Kumpel BM
    Transfus Clin Biol; 2002 Jan; 9(1):9-14. PubMed ID: 11889904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of IgG anti-D bound to D-positive red cells infused into D-negative subjects after intramuscular injection of monoclonal anti-D.
    Kumpel BM; Judson PA
    Transfus Med; 1995 Jun; 5(2):105-12. PubMed ID: 7655572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D.
    Kumpel BM
    Vox Sang; 1997; 72(1):45-51. PubMed ID: 9031501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal anti-D for prophylaxis of RhD haemolytic disease of the newborn.
    Kumpel BM
    Transfus Clin Biol; 1997 Jul; 4(4):351-6. PubMed ID: 9269715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.
    Kumpel BM; Rademacher TW; Rook GA; Williams PJ; Wilson IB
    Hum Antibodies Hybridomas; 1994; 5(3-4):143-51. PubMed ID: 7756579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance of red cells by monoclonal IgG3 anti-D in vivo is affected by the VF polymorphism of Fcgamma RIIIa (CD16).
    Kumpel BM; De Haas M; Koene HR; Van De Winkel JG; Goodrick MJ
    Clin Exp Immunol; 2003 Apr; 132(1):81-6. PubMed ID: 12653840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal anti-D-induced clearance of human D-positive red cells in a chimpanzee model.
    Blancher A; Socha WW; Roubinet F; Rowe AW; Broly H; Byrne P; Holuigue M; Bouzidi A; Huart JJ; Ruffié J
    Vox Sang; 1993; 65(1):47-54. PubMed ID: 8362514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human monoclonal antibody against Rh(D) antigen: partial characterization of the Rh(D) polypeptide from human erythrocytes.
    Bloy C; Blanchard D; Lambin P; Goossens D; Rouger P; Salmon C; Cartron JP
    Blood; 1987 May; 69(5):1491-7. PubMed ID: 3032309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional in vivo characterization of human monoclonal anti-D in NOD-scid mice.
    Bazin R; Aubin E; Boyer L; St-Amour I; Roberge C; Lemieux R
    Blood; 2002 Feb; 99(4):1267-72. PubMed ID: 11830475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human monoclonal antibodies against the rhesus D antigen from women with severe Rh immunization submitted to high-dose intravenous immunoglobulin treatment.
    del Aguila C; Guillén MV; de la Cámara C; Llopis R
    Vox Sang; 1994; 66(1):55-60. PubMed ID: 8146984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single recombinant anti-RhD IgG prevents RhD immunization: association of RhD-positive red blood cell clearance rate with polymorphisms in the FcgammaRIIA and FcgammaIIIA genes.
    Miescher S; Spycher MO; Amstutz H; De Haas M; Kleijer M; Kalus UJ; Radtke H; Hubsch A; Andresen I; Martin RM; Bichler J
    Blood; 2004 Jun; 103(11):4028-35. PubMed ID: 14976055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-Rho[D] antigen monoclonal antibodies. II. Serological characteristics of monoclonal IgG1 antibodies].
    Olovnikova NI; Belkina EV; Lemeneva LN; Berkovskiĭ AL; Deriugina EI; Chertkov IL
    Gematol Transfuziol; 1992; 37(9-10):5-9. PubMed ID: 1490578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of human heterohybridoma and lymphoblastoid cell lines specific for the Rh D and C antigens.
    Pasha RP; Roohi A; Shokri F
    Transfus Med; 2003 Apr; 13(2):83-92. PubMed ID: 12694553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine monoclonal antibodies reactive with a human monoclonal anti-RhD antibody (BRAD-5).
    Walker RY; Andrew S; Kumpel BM; Austin EB
    Transfus Med; 2000 Sep; 10(3):225-31. PubMed ID: 10972918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of Rh D antigen sites on weak D and D variant red cells by flow cytometry.
    Jones JW; Lloyd-Evans P; Kumpel BM
    Vox Sang; 1996; 71(3):176-83. PubMed ID: 8912461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of Rh D-positive red cells with monoclonal anti-D.
    Thomson A; Contreras M; Gorick B; Kumpel B; Chapman GE; Lane RS; Teesdale P; Hughes-Jones NC; Mollison PL
    Lancet; 1990 Nov; 336(8724):1147-50. PubMed ID: 1978026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal antibodies to Rho(D)-antigen of the Rhesus system. Obtaining the EBV-transformed B-lymphoblastoid human cell lines secreting IgG-anti-D antibodies].
    Deriugina EI; Olovnikova NI; Lemeneva LN; Belkina EV; Udalov GA; Chertkov IL
    Gematol Transfuziol; 1991 Aug; 36(8):11-6. PubMed ID: 1661249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.